You are here: Industry Insights > cancer

News List

'Cancer is an increasingly important health issue in the APAC region’ biospectrumasia
March 12, 2018
Australia’s Telix Pharmaceuticals is developing an advanced portfolio of radiopharmaceuticals products that address significant unmet medical need in renal, prostate and brain (glioblastoma) cancer.
Roche to acquire Flatiron Health to accelerate industry-wide development and delivery of breakthroug worldpharmanews
February 28, 2018
Roche and Flatiron Health, Inc. announced that the two partners have signed a definitive agreement under which Roche will acquire all shares of Flatiron Health.
Using injectable self-assembled nanomaterials for sustained delivery of drugs worldpharmanews
February 13, 2018
Because they can be programmed to travel the body and selectively target cancer and other sites of disease, nanometer-scale vehicles called nanocarriers can deliver higher concentrations of drugs to bombard specific areas of the body while minimizing syst
7 Key Cancer Trends For 2018 forbes
January 23, 2018
Here’s a list of major trends and issues that will affect the lives of cancer patients in 2018 -- By Elaine Schattner
5 Milestones Of 2017 In The War On Cancer forbes
December 26, 2017
An impressive 45 novel drugs have been approved by the FDA in 2017 so far — more than doubling last year’s total.
Using light-emitting nanoparticles may lead to earlier detection of cancer europeanpharmaceuticalreview
December 13, 2017
Light-emitting nanoprobes can detect cancer early and track the spread of tiny tumours…
JW Pharma releases cancer treatment trial results biospectrumasia
December 13, 2017
JW Pharmaceuticals expects CWP291 to become a new treatment that will replace standard therapies.
FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extens fda
December 01, 2017
FDA approves test to detect mutations in 324 genes, two genomic signatures. Second to be approved with proposed coverage under FDA/CMS Parallel Review Program.
Takeda spins off cancer assets to incubated startup fiercebiotech
November 23, 2017
The resulting biotech, Chordia Therapeutics, starts life with multiple oncology drugs, lab space at a Takeda site and funding from the Japanese firm and a VC syndicate.
LLS funds $46 Million in new research to find cures for cancer biospectrumasia
November 23, 2017
More than a dozen blood cancer therapies FDA approved in 2017 are a testament to LLS's impact on the cancer landscape.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page